Core Viewpoint - The company, Kaineng Health, has signed a framework agreement to acquire all equity and assets of several related companies from the Yuaneng Group for cash, while the Yuaneng Group retains its core assets and certain business operations [1] Group 1: Acquisition Details - The acquisition includes all equity and assets of Yuan Tian Biological, Jiyuan Meiyu, Kele Cat, and Lishui Dongxin [1] - The company currently holds a 43.70% stake in the Yuaneng Group and will continue to support the development of related industries [1] Group 2: Yuaneng Group's Retained Assets - Post-acquisition, the Yuaneng Group will retain its core park assets, cell storage business, and cell deployment business [1] - The Yuaneng Group is also responsible for the development and industrialization project of the "automated cell manufacturing factory" mandated by a national ministry [1]
开能健康:拟购买原能集团部分子公司全部出资